Endothelial cell-specific roles for tetrahydrobiopterin in myocardial function, cardiac hypertrophy, and response to myocardial ischemia-reperfusion injury
- PMID: 36735402
- PMCID: PMC9988535
- DOI: 10.1152/ajpheart.00562.2022
Endothelial cell-specific roles for tetrahydrobiopterin in myocardial function, cardiac hypertrophy, and response to myocardial ischemia-reperfusion injury
Abstract
The cofactor tetrahydrobiopterin (BH4) is a critical regulator of nitric oxide synthase (NOS) function and redox signaling, with reduced BH4 implicated in multiple cardiovascular disease states. In the myocardium, augmentation of BH4 levels can impact on cardiomyocyte function, preventing hypertrophy and heart failure. However, the specific role of endothelial cell BH4 biosynthesis in the coronary circulation and its role in cardiac function and the response to ischemia has yet to be elucidated. Endothelial cell-specific Gch1 knockout mice were generated by crossing Gch1fl/fl with Tie2cre mice, generating Gch1fl/flTie2cre mice and littermate controls. GTP cyclohydrolase protein and BH4 levels were reduced in heart tissues from Gch1fl/flTie2cre mice, localized to endothelial cells, with normal cardiomyocyte BH4. Deficiency in coronary endothelial cell BH4 led to NOS uncoupling, decreased NO bioactivity, and increased superoxide and hydrogen peroxide productions in the hearts of Gch1fl/flTie2cre mice. Under physiological conditions, loss of endothelial cell-specific BH4 led to mild cardiac hypertrophy in Gch1fl/flTie2cre hearts. Endothelial cell BH4 loss was also associated with increased neuronal NOS protein, loss of endothelial NOS protein, and increased phospholamban phosphorylation at serine-17 in cardiomyocytes. Loss of cardiac endothelial cell BH4 led to coronary vascular dysfunction, reduced functional recovery, and increased myocardial infarct size following ischemia-reperfusion injury. Taken together, these studies reveal a specific role for endothelial cell Gch1/BH4 biosynthesis in cardiac function and the response to cardiac ischemia-reperfusion injury. Targeting endothelial cell Gch1 and BH4 biosynthesis may provide a novel therapeutic target for the prevention and treatment of cardiac dysfunction and ischemia-reperfusion injury.NEW & NOTEWORTHY We demonstrate a critical role for endothelial cell Gch1/BH4 biosynthesis in coronary vascular function and cardiac function. Loss of cardiac endothelial cell BH4 leads to coronary vascular dysfunction, reduced functional recovery, and increased myocardial infarct size following ischemia/reperfusion injury. Targeting endothelial cell Gch1 and BH4 biosynthesis may provide a novel therapeutic target for the prevention and treatment of cardiac dysfunction, ischemia injury, and heart failure.
Keywords: cardiac function; hypertrophy; ischemia-reperfusion injury; nitric oxide synthase; tetrahydrobiopterin.
Conflict of interest statement
No conflicts of interest, financial or otherwise, are declared by the authors.
Figures
Similar articles
-
A key role for tetrahydrobiopterin-dependent endothelial NOS regulation in resistance arteries: studies in endothelial cell tetrahydrobiopterin-deficient mice.Br J Pharmacol. 2017 Apr;174(8):657-671. doi: 10.1111/bph.13728. Epub 2017 Mar 13. Br J Pharmacol. 2017. PMID: 28128438 Free PMC article.
-
Cell-autonomous role of endothelial GTP cyclohydrolase 1 and tetrahydrobiopterin in blood pressure regulation.Hypertension. 2014 Sep;64(3):530-40. doi: 10.1161/HYPERTENSIONAHA.114.03089. Epub 2014 Apr 28. Hypertension. 2014. PMID: 24777984 Free PMC article.
-
Regulation of iNOS function and cellular redox state by macrophage Gch1 reveals specific requirements for tetrahydrobiopterin in NRF2 activation.Free Radic Biol Med. 2015 Feb;79:206-16. doi: 10.1016/j.freeradbiomed.2014.10.575. Epub 2014 Nov 6. Free Radic Biol Med. 2015. PMID: 25451639 Free PMC article.
-
Recoupling the cardiac nitric oxide synthases: tetrahydrobiopterin synthesis and recycling.Curr Heart Fail Rep. 2012 Sep;9(3):200-10. doi: 10.1007/s11897-012-0097-5. Curr Heart Fail Rep. 2012. PMID: 22711313 Free PMC article. Review.
-
Catecholamines and Parkinson's disease: tyrosine hydroxylase (TH) over tetrahydrobiopterin (BH4) and GTP cyclohydrolase I (GCH1) to cytokines, neuromelanin, and gene therapy: a historical overview.J Neural Transm (Vienna). 2024 Jun;131(6):617-630. doi: 10.1007/s00702-023-02673-y. Epub 2023 Aug 28. J Neural Transm (Vienna). 2024. PMID: 37638996 Review.
Cited by
-
Oxidative Stress and Erectile Dysfunction: Pathophysiology, Impacts, and Potential Treatments.Curr Issues Mol Biol. 2024 Aug 14;46(8):8807-8834. doi: 10.3390/cimb46080521. Curr Issues Mol Biol. 2024. PMID: 39194738 Free PMC article. Review.
-
Multiple Shades of Gray-Macrophages in Acute Allograft Rejection.Int J Mol Sci. 2023 May 4;24(9):8257. doi: 10.3390/ijms24098257. Int J Mol Sci. 2023. PMID: 37175964 Free PMC article. Review.
-
Redox Homeostasis and Molecular Biomarkers in Precision Therapy for Cardiovascular Diseases.Antioxidants (Basel). 2024 Sep 25;13(10):1163. doi: 10.3390/antiox13101163. Antioxidants (Basel). 2024. PMID: 39456418 Free PMC article. Review.
References
-
- Vasquez-Vivar J, Martasek P, Whitsett J, Joseph J, Kalyanaraman B. The ratio between tetrahydrobiopterin and oxidized tetrahydrobiopterin analogues controls superoxide release from endothelial nitric oxide synthase: an EPR spin trapping study. Biochem J 362: 733–739, 2002. doi:10.1042/0264-6021:3620733. - DOI - PMC - PubMed
-
- Crabtree MJ, Tatham AL, Al-Wakeel Y, Warrick N, Hale AB, Cai S, Channon KM, Alp NJ. Quantitative regulation of intracellular endothelial nitric oxide synthase (eNOS) coupling by both tetrahydrobiopterin-eNOS stoichiometry and biopterin redox status: Insights from cells with tet-regulated GTP cyclohydrolase I expression. J Biol Chem 284: 1136–1144, 2009. doi:10.1074/jbc.M805403200. - DOI - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
- RG/12/5/29576/BHF_/British Heart Foundation/United Kingdom
- FS/14/56/31049/BHF_/British Heart Foundation/United Kingdom
- DH_/Department of Health/United Kingdom
- PG/15/35/31403/BHF_/British Heart Foundation/United Kingdom
- CH/16/1/32013/BHF_/British Heart Foundation/United Kingdom
- RE/13/1/30181/BHF_/British Heart Foundation/United Kingdom
- CH/12/3/29609/BHF_/British Heart Foundation/United Kingdom
- 090532/Z/09/Z/WT_/Wellcome Trust/United Kingdom
- RG/F/22/110085/BHF_/British Heart Foundation/United Kingdom
- RG/17/10/32859/BHF_/British Heart Foundation/United Kingdom
- RG/16/12/32451/BHF_/British Heart Foundation/United Kingdom
- PG/19/48/34433/BHF_/British Heart Foundation/United Kingdom
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases